Applications published 12 August 2009

Aquaporin modulators and methods of using them for the treatment of oedema and fluid imbalance
Flynn, Gary; Yool, Andrea; Migliati, Elton; Ritter, Leslie 2086329*

Phosphonate inhalant formulations and method for using the same
Teikoku Pharma 2086330*

Methods of treating neuronal disorders using MTNF peptides and analogues thereof
Genervon Biopharmaceuticals 2086331*

• Bone marrow-derived mesenchymal stem cells as a source of neural progenitors
Multiple Sclerosis Research Centre of New York 2086332*

• Isolated myeloid-like cell populations and methods of treatment therewith
The Scripps Research Institute 2086333*

• A bleomycin preparation for use against skin tumours
Chopra, Sunil 2086501*

• Punctual plug comprising a water-insoluble polymeric matrix
Alcon Research 2086502*

• Sustained release drug delivery systems comprising a water-soluble therapeutic agent and a release modifier
Allergan 2086503*

• Diclofenac gel
Nuvo Research 2086504*

• Injectable depot compsn and its process of preparation
Panacea Biotec 2086505*

• Preparation of heavy metal-containing nano-liposomes and their uses in medical therapy
SB Biotechnologies 2086506*

• A spinal nucleus pulposus implant
Scil Technology 2086507*

• Cationic colloidal carriers for delivery of active agents to the blood-brain barrier in the course of neuroinflammatory diseases
MediGene 2086508*

• Escitalopram and solid pharmaceutical compsn containing the same
Ratiopharm 2086509*

• Preparation of a free-flowing molecular dispersion of clopidogrel base
Gutunka, Venkateswarlu; Reddy, Bhumireddy; Pandey, Harish 2086510*

• Polymer-based antimicrobial agents, methods of making said agents, and products and applications using said agents
Smart Anti-Microbial Solutions 2086511*

• Dry granulated pharmaceutical compsns and methods for producing same
Janssen Pharmaceutica 2086512*

• Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
Samyang 2086513*

• Pharmaceutical compsns comprising an S1P modulator
Novartis 2086514*

• Rate-controlled bioadhesive oral dosage formulations
Vaunnex 2086515*

• Melt-processed Imatinib dosage form
Abbott; Novartis 2086516*

• Pharmaceutical dosage form
Nobel ILAC 2086517*

• Darusentan oral dosage form
Gilead Colorado 2086518*

• Controlled release complex compsn comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors
Hanell Pharmaceutical 2086519*

• Imatinib compsns
Teva Pharmaceutical Industries 2086520*

• Self-assembled nanoparticles composed of transmembrane peptides and their application for specific intra-tumour delivery of anti-cancer drugs
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services 2086521*

• Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement
LTS Lohmann Therapie-Systeme 2086522*

• Inhaler devices and bespoke pharmaceutical compsns
Vectura 2086523*

• Transnasal anticonvulsive pharmaceutical compsn
SK Holdings 2086524*

• Method of radio-sensitising tumours using a radio-sensitising agent
Cephalon 2086525*

• Induction of an immune-response against dengue virus using prime-boost approach
The United States of America as Represented by the Secretary of the Navy 2086526*

• Systems for effecting cessation of tobacco use
Aradigm 2086527*

• Na+/K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases
University of Toledo 2086528*

• Antimicrobial compsns and related applications
DeLaval Holding 2086529*

• Use of gabapentin and pregabalin prodrugs for treating tinnitus
XenoPort 2086530*

• Compsns and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
Amira Pharmaceuticals 2086531*

• Use for treating obesity and diabetes
Amorepacific 2086532*

• Use of an adenosine antagonist
Centre de Recherche Publique de la Sante (CRP-Sante) 2086533*

• Use of pramipexazole or a salt thereof for the treatment of Parkinson's disease
Boehringer Ingelheim International; Boehringer Ingelheim Pharma 2086536*

• Imidazo[2,1-B]thiazoles and their use as pharmaceuticals
Sanofi-Aventis 2086537*